Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (9307)	6/7/1998 4:55:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

Did anybody here call or e-mail Vivus last week to give some input on things they would like to hear about on Monday? If so please share your communications.

To: VLAD who wrote (9307)	6/7/1998 10:01:00 PM
From: Edderd	Read Replies (1) \| Respond to of 23519

VLAD Sorry I was checking out the prostate cancer info. I read the abstracts and as I said before the studies were very poorly done. I'm surprised anyone would pay much attention. Vivus response to the one study was very appropriate and showed what a foolish study it was. Impotence was not the big interest at the meeting. Viagra is old news to urologists. It's still too early to see how much dropout will occur with Viagra but since the market is so large it will be a significant number. The big question is can they be converted to MUSE. If so we will be smiling sometime in the furture. The analysts are not able to decipher good reports from stupid ones so it's no surprise to see a few downgrades. I did get to talk to Nina F face to face but not much to talk about in facts. FDA by the end of June. Ed